Loading…

Complexed prostate-specific antigen as a staging tool: results based on a multicenter prospective evaluation of complexed prostate-specific antigen in cancer diagnosis

Within a 7-site prospective evaluation of the Bayer complexed prostate-specific antigen PSA (cPSA) assay, we analyzed the ability of cPSA to predict extracapsular extension (ECE) before radical prostatectomy. Included in this analysis were 152 men diagnosed with cancer, who subsequently underwent ra...

Full description

Saved in:
Bibliographic Details
Published in:Urology (Ridgewood, N.J.) N.J.), 2002-10, Vol.60 (4), p.10-17
Main Authors: Taneja, Samir S, Hsu, Elias I, Cheli, Carol D, Walden, Paul, Bartsch, Georg, Horninger, Wolfgang, Babaian, Richard J, Fritsche, Herbert A, Childs, Stacy, Stamey, Thomas A, Sokoll, Lori J, Chan, Daniel W, Brawer, Michael K, Partin, Alan W, Lepor, Herbert
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Within a 7-site prospective evaluation of the Bayer complexed prostate-specific antigen PSA (cPSA) assay, we analyzed the ability of cPSA to predict extracapsular extension (ECE) before radical prostatectomy. Included in this analysis were 152 men diagnosed with cancer, who subsequently underwent radical prostatectomy. Sera were tested with the Bayer total PSA (tPSA) and cPSA assays, and the Beckman free PSA (fPSA) and tPSA assays. Treating surgical pathology result as a binary variable (organ confined vs ECE), mean tPSA, cPSA, fPSA/tPSA (f/tPSA) ratios, tPSA density (tPSAD), and cPSA density (cPSAD) were compared by receiver operating characteristic (ROC) curves and univariate analysis. In all, 28 men (18.4%) had pathologically identified ECE. Between those with and without ECE, significant differences were observed for tPSA ( P = 0.0127), cPSA ( P = 0.0120), tPSAD ( P = 0.0001), and cPSAD ( P = 0.0002), but not f/tPSA ( P = 0.3774) or c/tPSA ( P = 0.2882). All tested parameters except f/tPSA ( P = 0.376) and c/tPSA ( P = 0.288) predicted ECE ( P
ISSN:0090-4295
1527-9995
DOI:10.1016/S0090-4295(02)01720-X